We are a global medical technology company with headquarters in the Lake Geneva region of Switzerland. Established in 1997, we represent the industry standard in the fields of cell therapy manufacturing and cord blood banking. From laboratories to hospitals, hundreds of cell processing procedures depend on our technology every day.
Long lasting partnerships are important to us. We believe a commitment to innovation and quality is at the heart of what enables us to tailor solutions with our customers. Our network of subsidiaries and distribution partners ensures we can cater to markets across more than 50 countries.
See below for our new Sefia device
Our Sefia platform is a new technology developed specifically for cell and gene therapy manufacturing. It combines with dedicated software and kits to process both small and large volumes of cellular material.
See more information at sefia.biosafe.ch
Commercial release pending and for investigational use only.